GB201501115D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB201501115D0 GB201501115D0 GBGB1501115.8A GB201501115A GB201501115D0 GB 201501115 D0 GB201501115 D0 GB 201501115D0 GB 201501115 A GB201501115 A GB 201501115A GB 201501115 D0 GB201501115 D0 GB 201501115D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1501115.8A GB201501115D0 (en) | 2015-01-23 | 2015-01-23 | Compounds |
PCT/GB2016/050124 WO2016116752A1 (en) | 2015-01-23 | 2016-01-21 | Antileishmanial pyrazolopyrimidines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1501115.8A GB201501115D0 (en) | 2015-01-23 | 2015-01-23 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201501115D0 true GB201501115D0 (en) | 2015-03-11 |
Family
ID=52673821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1501115.8A Ceased GB201501115D0 (en) | 2015-01-23 | 2015-01-23 | Compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201501115D0 (en) |
WO (1) | WO2016116752A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3894413B1 (en) | 2018-12-12 | 2023-11-15 | Merck Sharp & Dohme LLC | Pyrazolopyrimidine pde9 inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7405220B2 (en) | 2004-06-09 | 2008-07-29 | Hoffmann-La Roche Inc. | Pyrazolopyrimidines |
EP1880791A1 (en) | 2006-07-21 | 2008-01-23 | Aleris Aluminum Koblenz GmbH | Process and apparatus for laser joining two components through the use of a laminar inert gas flow coaxial to a metal filler wire |
WO2008094602A2 (en) | 2007-01-30 | 2008-08-07 | Biogen Idec Ma Inc. | 1-h-pyrazolo (3,4b) pyrimidine derivatives and their use as modulators of mitotic kinases |
-
2015
- 2015-01-23 GB GBGB1501115.8A patent/GB201501115D0/en not_active Ceased
-
2016
- 2016-01-21 WO PCT/GB2016/050124 patent/WO2016116752A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2016116752A1 (en) | 2016-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201510019D0 (en) | Compounds | |
GB201514754D0 (en) | Compounds | |
GB201514751D0 (en) | Compounds | |
HUE054351T2 (en) | Compounds | |
GB201508747D0 (en) | Compounds | |
GB201520500D0 (en) | Compounds | |
GB201520499D0 (en) | Compounds | |
GB201508864D0 (en) | Compounds | |
IL253813B (en) | Diaza-benzofluoranthrene compounds | |
GB201510493D0 (en) | Compounds | |
HUE052932T2 (en) | Compounds | |
GB201521682D0 (en) | Compounds | |
GB201520419D0 (en) | Compounds | |
GB201508857D0 (en) | Compounds | |
GB201503926D0 (en) | Compounds | |
GB201501115D0 (en) | Compounds | |
GB201522246D0 (en) | Compounds | |
GB201521912D0 (en) | Compounds | |
GB201521440D0 (en) | Compounds | |
GB201521086D0 (en) | Compounds | |
GB201519965D0 (en) | Compounds | |
GB201519969D0 (en) | Compounds | |
GB201519549D0 (en) | Compounds | |
GB201519213D0 (en) | Compounds | |
GB201519212D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |